Treatment choice for early-stage hepatocellular carcinoma in real-world practice: impact of treatment stage migration to transarterial chemoembolization and treatment response on survival-Reference-Cited by-同舟云学术

Treatment choice for early-stage hepatocellular carcinoma in real-world practice: impact of treatment stage migration to transarterial chemoembolization and treatment response on survival

Published:2018-11-02 Issue:10-11 Volume:53 Page:1368-1375
ISSN:0036-5521
Container-title:Scandinavian Journal of Gastroenterology
language:en
Short-container-title:Scandinavian Journal of Gastroenterology

Author:

Roberts Stuart K.¹,Gazzola Alessia¹,Lubel John²,Gow Paul³,Bell Sally⁴,Nicoll Amanda²⁵,Dev Anouk⁶,Fink Michael A.⁷,Sood Siddharth⁵,Knight Virginia⁶,Hong Thai⁴,Paul Eldho⁸,Mishra Gauri⁶,Majeed Ammar¹,Kemp William¹,

Affiliation:

1. Department of Gastroenterology, Alfred Hospital, and Monash University, Melbourne, Australia;

2. Department of Gastroenterology, Eastern Health and Eastern Health Clinical School, Monash University, Melbourne, Australia;

3. Department of Gastroenterology, Austin Hospital, Heidelberg, Australia;

4. Department of Gastroenterology, St Vincent’s Hospital, Fitzroy, Australia;

5. Department of Gastroenterology, Royal Melbourne Hospital, Parkville, Australia;

6. Department of Gastroenterology, Monash Medical Centre, Clayton, Australia;

7. Department of Surgery, Austin Hospital, The University of Melbourne, Heidelberg, Australia;

8. Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Clinical Haematology Department, Alfred Hospital, Melbourne, Australia

Publisher

Informa UK Limited

Subject

Gastroenterology

Link

https://www.tandfonline.com/doi/pdf/10.1080/00365521.2018.1517277

Reference26 articles.

1. Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification

2. Hepatocellular carcinoma

3. Outcomes of patients with hepatocellular carcinoma referred for percutaneous radiofrequency ablation at a tertiary center: Analysis focused on the feasibility with the use of ultrasonography guidance

4. Radiofrequency ablation for hepatocellular carcinoma in so-called high-risk locations

5. Systemic Therapy for Hepatocellular Carcinoma: The Issue of Treatment Stage Migration and Registration of Progression Using the BCLC-Refined RECIST

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A randomised controlled trial of Standard Of Care versus RadioAblaTion in Early Stage HepatoCellular Carcinoma (SOCRATES HCC);BMC Cancer;2024-07-08

2. Comparison of outcomes following surgical resection, percutaneous ablation or stereotactic body radiation therapy in early‐stage, solitary and small (≤3 cm) treatment‐naïve hepatocellular carcinoma;Cancer Medicine;2024-02

3. Ablation margin quantification after thermal ablation of malignant liver tumors: How to optimize the procedure? A systematic review of the available evidence;European Journal of Radiology Open;2023-12

4. Definitive Stereotactic Body Radiation Therapy in Early-Stage Solitary Hepatocellular Carcinoma: An Australian Multi-Institutional Review of Outcomes;Clinical Oncology;2023-12

5. Evaluating treatment response following locoregional therapy for hepatocellular carcinoma: A review of the available serological and radiological tools for assessment;JGH Open;2023-04